Bicara Therapeutics Inc. SEC filings BCAX
Bicara Therapeutics Inc. has 263 filings in SEC EDGAR's recent list, going back to Jun 10, 2024. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Apr 21, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 25, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 144 | Notice of proposed sale | Oct 21, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 7, 2026 | — |
| 4 | Insider transaction | Sep 10, 2026 | Sep 8, 2026 |
| 144 | Notice of proposed sale | Sep 8, 2026 | — |
| 144 | Notice of proposed sale | Sep 8, 2026 | — |
| 8-K |
Current report
Material agreement
|
Aug 25, 2026 | Aug 21, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| 3 | Initial insider ownership | Aug 14, 2026 | Aug 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 4 | Insider transaction | Aug 12, 2026 | Aug 10, 2026 |
| 4 | Insider transaction | Aug 12, 2026 | Aug 10, 2026 |
| 4 | Insider transaction | Aug 12, 2026 | Aug 10, 2026 |
| S-8 | Employee stock plan registration | Aug 11, 2026 | — |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 144 | Notice of proposed sale | Aug 10, 2026 | — |
| 144 | Notice of proposed sale | Aug 10, 2026 | — |
| 144 | Notice of proposed sale | Aug 10, 2026 | — |
| 4 | Insider transaction | Jul 29, 2026 | Jul 28, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 28, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 28, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 28, 2026 | Jul 23, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 27, 2026 | — |
| 4 | Insider transaction | Jul 14, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 8, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 8, 2026 |
| 144 | Notice of proposed sale | Jul 10, 2026 | — |
| 144 | Notice of proposed sale | Jul 8, 2026 | — |
| 144 | Notice of proposed sale | Jul 8, 2026 | — |
| 144 | Notice of proposed sale | Jul 8, 2026 | — |
| 144 | Notice of proposed sale | Jul 7, 2026 | — |
| 144 | Notice of proposed sale | Jun 25, 2026 | — |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2026 | Jun 9, 2026 |
| 144 | Notice of proposed sale | Jun 1, 2026 | — |
| 4 | Insider transaction | May 26, 2026 | May 21, 2026 |
| 144 | Notice of proposed sale | May 26, 2026 | — |
| 8-K |
Current report
Other events
|
May 21, 2026 | May 21, 2026 |
| 144 | Notice of proposed sale | May 21, 2026 | — |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 15, 2026 |
| 144 | Notice of proposed sale | May 18, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 144 | Notice of proposed sale | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 4 | Insider transaction | May 12, 2026 | May 8, 2026 |
| 3 | Initial insider ownership | May 12, 2026 | May 8, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 8, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 6, 2026 | — |
| 4 | Insider transaction | Apr 28, 2026 | Apr 27, 2026 |
| 144 | Notice of proposed sale | Apr 27, 2026 | — |
| ARS | Annual report to shareholders | Apr 27, 2026 | Apr 21, 2026 |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Apr 21, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 21, 2026 |
| 144 | Notice of proposed sale | Apr 21, 2026 | — |
| 4 | Insider transaction | Apr 20, 2026 | Apr 16, 2026 |
| 144 | Notice of proposed sale | Apr 20, 2026 | — |
| 4 | Insider transaction | Apr 17, 2026 | Apr 15, 2026 |
| 144 | Notice of proposed sale | Apr 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 8, 2026 | — |
| S-8 | Employee stock plan registration | Mar 31, 2026 | — |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Mar 26, 2026 | Mar 25, 2026 |
| 144 | Notice of proposed sale | Mar 25, 2026 | — |
| 4 | Insider transaction | Mar 24, 2026 | Mar 23, 2026 |
| 144 | Notice of proposed sale | Mar 23, 2026 | — |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 144 | Notice of proposed sale | Mar 20, 2026 | — |
| 144 | Notice of proposed sale | Mar 19, 2026 | — |
| 144 | Notice of proposed sale | Mar 18, 2026 | — |
| 4 | Insider transaction | Mar 17, 2026 | Mar 16, 2026 |
| 144 | Notice of proposed sale | Mar 16, 2026 | — |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 144 | Notice of proposed sale | Mar 9, 2026 | — |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 144 | Notice of proposed sale | Mar 6, 2026 | — |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 144 | Notice of proposed sale | Mar 5, 2026 | — |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 3, 2026 | — |
| 144 | Notice of proposed sale | Mar 3, 2026 | — |
| 144 | Notice of proposed sale | Mar 3, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 2, 2026 | — |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 8-K |
Current report
Material agreement, Results of operations
|
Feb 26, 2026 | Feb 24, 2026 |
| 424B5 | Prospectus supplement | Feb 26, 2026 | — |
| 144 | Notice of proposed sale | Feb 25, 2026 | — |
| FWP | Free writing prospectus | Feb 25, 2026 | — |
| 424B5 | Prospectus supplement | Feb 24, 2026 | — |
| 8-K |
Current report
Other events
|
Feb 19, 2026 | Feb 19, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 12, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 144 | Notice of proposed sale | Jan 22, 2026 | — |
| 144 | Notice of proposed sale | Jan 22, 2026 | — |
| 4 | Insider transaction | Jan 20, 2026 | Jan 15, 2026 |
| 144 | Notice of proposed sale | Jan 15, 2026 | — |
| 8-K |
Current report
Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Dec 29, 2025 | Dec 26, 2025 |
| 4 | Insider transaction | Dec 29, 2025 | Dec 26, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 144 | Notice of proposed sale | Dec 22, 2025 | — |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 15, 2025 |
| 144 | Notice of proposed sale | Dec 15, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 8, 2025 | Dec 6, 2025 |
| EFFECT | Filing | Nov 26, 2025 | — |
| 424B5 | Prospectus supplement | Nov 26, 2025 | — |
| 4 | Insider transaction | Nov 25, 2025 | Nov 21, 2025 |
| 4 | Insider transaction | Nov 25, 2025 | Nov 21, 2025 |
| 4 | Insider transaction | Nov 25, 2025 | Nov 24, 2025 |
| 4 | Insider transaction | Nov 25, 2025 | Nov 24, 2025 |
| 144 | Notice of proposed sale | Nov 25, 2025 | — |
| 144 | Notice of proposed sale | Nov 24, 2025 | — |
| 144 | Notice of proposed sale | Nov 24, 2025 | — |
| 144 | Notice of proposed sale | Nov 24, 2025 | — |
| CORRESP | Letter to the SEC | Nov 24, 2025 | — |
| 144 | Notice of proposed sale | Nov 21, 2025 | — |
| 144 | Notice of proposed sale | Nov 21, 2025 | — |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 4 | Insider transaction | Oct 20, 2025 | Oct 16, 2025 |
| 4 | Insider transaction | Oct 16, 2025 | Oct 15, 2025 |
| 144 | Notice of proposed sale | Oct 16, 2025 | — |
| 4 | Insider transaction | Oct 15, 2025 | Oct 13, 2025 |
| 144 | Notice of proposed sale | Oct 15, 2025 | — |
| 144 | Notice of proposed sale | Oct 15, 2025 | — |
| 144 | Notice of proposed sale | Oct 14, 2025 | — |
| 4 | Insider transaction | Oct 10, 2025 | Oct 9, 2025 |
| 4 | Insider transaction | Oct 10, 2025 | Oct 9, 2025 |
| 144 | Notice of proposed sale | Oct 9, 2025 | — |
| 144 | Notice of proposed sale | Oct 9, 2025 | — |
| 4 | Insider transaction | Oct 8, 2025 | Oct 6, 2025 |
| 4 | Insider transaction | Oct 8, 2025 | Oct 6, 2025 |
| 144 | Notice of proposed sale | Oct 8, 2025 | — |
| 144 | Notice of proposed sale | Oct 7, 2025 | — |
| 144 | Notice of proposed sale | Oct 7, 2025 | — |
| 144 | Notice of proposed sale | Oct 6, 2025 | — |
| 144 | Notice of proposed sale | Oct 6, 2025 | — |
| S-3 | Shelf registration | Oct 3, 2025 | — |
| 4 | Insider transaction | Oct 1, 2025 | Sep 29, 2025 |
| 144 | Notice of proposed sale | Sep 29, 2025 | — |
| 4 | Insider transaction | Sep 17, 2025 | Sep 15, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 31, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 17, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 17, 2025 | — |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 144 | Notice of proposed sale | Jun 16, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Material agreement
|
Jun 6, 2025 | Jun 2, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 9, 2025 |
| S-8 | Employee stock plan registration | Mar 28, 2025 | — |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2025 | Mar 27, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 144 | Notice of proposed sale | Mar 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 3, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BCAX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2023658
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.